Standard Specimen Reference Set: Liver
134
- Befeler, Alex — Saint Louis University
- Schwartz, Myron — Mount Sinai Hospital
- Roberts, Lewis — Mayo Clinic
- Harnois, Denise — Mayo Clinic Jacksonville
- Feng, Ziding — Fred Hutchinson Cancer Research Center
- Srivastava, Sudhir — National Cancer Institute
- Nguyen, Mindie — Stanford University
- Reddy, Rajender — University of Pennsylvania
- Volk, Michael L. — University of Michigan
Case/control
UNKNOWN
G.I. and Other Associated Cancers Research Group
Utilize the remaining specimens collected under the DCP protocol to develop and validate markers for the early detection of HCC
Specific Aims
Aim 1: To determine the sensitivity and specificity of des-gamma carboxyprothrombin (DCP) for the
diagnosis of early hepatocellular carcinoma (HCC).
Aim 2: To compare the accuracy of DCP and Alpha-fetoprotein (AFP) for the diagnosis of early HCC.
Aim 3: To determine whether demographic or etiology of underlying liver disease alter the expression of
DCP or AFP.
There are currently no biomarkers annotated for this protocol.
No datasets are currently associated with this protocol.
